Cargando…
Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use
Self-assembling nanoparticles (SANPs) promise an effective delivery of bisphosphonates or microRNAs in the treatment of glioblastoma (GBM) and are obtained through the sequential mixing of four components immediately before use. The self-assembling approach facilitates technology transfer, but the c...
Autores principales: | Abate, Marianna, Scotti, Lorena, Nele, Valeria, Caraglia, Michele, Biondi, Marco, De Rosa, Giuseppe, Leonetti, Carlo, Campani, Virginia, Zappavigna, Silvia, Porru, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102012/ https://www.ncbi.nlm.nih.gov/pubmed/35563529 http://dx.doi.org/10.3390/ijms23095138 |
Ejemplares similares
-
Chitosan-Based Polyelectrolyte Complexes for Doxorubicin and Zoledronic Acid Combined Therapy to Overcome Multidrug Resistance
por: Giarra, Simona, et al.
Publicado: (2018) -
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid
por: Porru, Manuela, et al.
Publicado: (2014) -
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer
por: Abate, Marianna, et al.
Publicado: (2023) -
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells
por: Zappavigna, Silvia, et al.
Publicado: (2019) -
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells
por: Kopecka, Joanna, et al.
Publicado: (2015)